###begin article-title 0
Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
In general, inflammation plays a role in most bladder pathologies and represents a defense reaction to injury that often times is two edged. In particular, bladder neurogenic inflammation involves the participation of mast cells and sensory nerves. Increased mast cell numbers and tryptase release represent one of the prevalent etiologic theories for interstitial cystitis and other urinary bladder inflammatory conditions. The activity of mast cell-derived tryptase as well as thrombin is significantly increased during inflammation. Those enzymes activate specific G-protein coupled proteinase-activated receptors (PAR)s.
###end p 3
###begin p 4
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
Four PARs have been cloned so far, and not only are all four receptors highly expressed in different cell types of the mouse urinary bladder, but their expression is altered during experimental bladder inflammation. We hypothesize that PARs may link mast cell-derived proteases to bladder inflammation and, therefore, play a fundamental role in the pathogenesis of cystitis.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 405 412 <span type="species:ncbi:562">E. coli</span>
Here, we demonstrate that in addition to the mouse urinary bladder, all four PA receptors are also expressed in the J82 human urothelial cell line. Intravesical administration of PAR-activating peptides in mice leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P, and antigen was strongly attenuated by PAR1-, and to a lesser extent, by PAR2-deficiency.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
Our results reveal an overriding participation of PAR1 in bladder inflammation, provide a working model for the involvement of downstream signaling, and evoke testable hypotheses regarding the role of PARs in bladder inflammation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestations of cystitis.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 409 410 409 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 519 520 519 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 657 658 657 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 789 791 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 507 515 <span type="species:ncbi:9606">patients</span>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
In general, inflammation plays a role in most bladder pathologies, including bladder cancer [1-4] and represents a defensive reaction to injury caused by physical damage, chemical substances, micro-organisms, or other agents [1,2]. In particular, bladder neurogenic inflammation involves the participation of mast cells and sensory nerves. Evidence for a role of mast cells in cystitis was reviewed recently [5] and includes the presence of mast cells containing tryptase in the bladder [6] and urine of IC patients [6,7], and that mast cell counts in IC patients are one of the few features significantly associated with night-time frequency of urination [8]. We have previously presented direct evidence indicating a key role for mast cells and their products in bladder inflammation [9-11], and others emphasized the role of mast cell products in bladder disorders [12-14].
###end p 10
###begin p 11
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
As a consequence of inflammation, products of mast cell degranulation, such as tryptase, can be found in the urine of cystitis patients [15]. In addition to tryptase, other serine proteases such as thrombin and trypsin are produced during tissue damage and make important contributions to tissue responses to injury, repair, cell survival, inflammation [16-19], and pain [20-24]. Tissue responses to these enzymes are modulated by protease-activated receptors (PARs), a unique class of G protein-coupled receptors that use a fascinating mechanism to convert an extracellular proteolytic cleavage event into a trans-membrane signal. These receptors carry their own ligands, which remain cryptic until unmasked by receptor cleavage (for a review, please see references [20,23,25,26]).
###end p 11
###begin p 12
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 540 543 540 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 737 739 737 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 785 787 785 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 306 311 <span type="species:ncbi:9606">human</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
###xml 875 880 <span type="species:ncbi:9606">human</span>
Four PARs have been cloned so far, and all four PARs are co-expressed in the mouse bladder urothelium [27], with PAR2 and PAR3 being the most abundant in the bladder epithelial layer. Although information regarding the presence of PARs in human urothelial cells is scanty, indirect evidence indicates that human cancer urothelial cells, such as J82, augment the conversion of prothrombin to thrombin, a key activator of PARs [28]. In addition, thrombin and other elements of the coagulation cascade activate J82 carcinoma cells, inducing Ca2+ mobilization, phospholipase C activity, and cell migration [29]. Another human bladder cell line, RT4, responds to thrombin, tryptase or PAR-APs with an increase in intracellular phospholipase A2 activity, arachidonic acid and prostaglandin E2 release [30]. In this work, we determined whether all four receptors are present in the human urothelial J82 cell line.
###end p 12
###begin p 13
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 540 542 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 886 888 886 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
###xml 182 186 <span type="species:ncbi:10116">rats</span>
###xml 599 604 <span type="species:ncbi:10090">mouse</span>
###xml 1198 1201 <span type="species:ncbi:10116">rat</span>
In addition to the urothelium, PAR1 and PAR2 are also expressed in mouse detrusor muscle, and PAR4 is expressed in mouse peripheral nerves and plexus cell bodies [27]. Similarly, in rats PAR2, 3, and 4 are expressed in urothelium, detrusor muscle, and bladder nerve fibers, and bladder afferent cells in dorsal root ganglia express PAR2 to 4 [31]. Confocal microscopy has revealed the co-localization of PAR2, 3, and 4 with protein gene products 9.5 and vanilloid receptor 1, suggesting that PARs are distributed in C-fiber bladder nerves [31]. In addition, PARs are differentially modulated during mouse bladder inflammation. Urothelial PAR2 and, to a lesser extent, PAR1 are down-regulated in acute inflammation whereas PAR3 and PAR4 are up-regulated [27]. Bladder fibroblasts were found to present a clear demarcation in PAR expression in response to acute and chronic inflammation [27]. Additional evidence for the participation of PARs in the bladder inflammatory response was the finding that known pro-inflammatory stimuli such as LPS, substance P, and antigen challenge induce an increase in PAR4 RNA within four hours [32]. Upregulation of PAR protein levels have been shown to be part of rat bladder responses to cyclophosphamide [31].
###end p 13
###begin p 14
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 102 103 102 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
In order to better understand the role of PARs in cystitis, we used a well-established mouse model [1,2,26] to determine the relative potency of PAR-activating peptides (PAR-APs). PAR3-AP was not included in this research because of a lack of specificity of the available reagent. Comparison of inflammatory responses in wild type, PAR1- and PAR2-deficient mice, revealed a mandatory role of PAR1 and, to a lesser extent, PAR2 in mediating bladder responses to a variety of pro-inflammatory stimuli.
###end p 14
###begin p 15
The combination of morphological results reveals an overriding participation of PAR1 receptors in bladder inflammation and provides a working model to investigate the inflammatory cascade downstream of PAR activation.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human urothelial cell line expresses all four PARs
###end title 17
###begin p 18
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A&#8211;E</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A&#8211;B</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 348 353 <span type="species:ncbi:9606">human</span>
In order to extend our previous results obtained with the mouse bladder [27], we also tested the presence of PA receptors in the J82 human urothelial cancer cell line. Our results indicate all four PARs are detectable at the protein level by immunohistochemistry (Figure 1A-E) and at the message level by polymerase chain reaction (Figure 2A-B) in human urothelial cancer cell line.
###end p 18
###begin p 19
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-E</bold>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 447 451 <span type="species:ncbi:9925">goat</span>
###xml 457 463 <span type="species:ncbi:9986">rabbit</span>
A-E. PAR immunohistochemistry in J82 human urothelial carcinoma cell line. Representative photomicrograph obtained in J82 cell line stained with PAR specific antibodies. J82 cells were fixed and incubated with primary polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies: A = PAR-1 (1:20), B = PAR-2 (1:100), C = PAR-3 (1:5), and D = PAR-4 (1:50). Slides were washed and incubated with biotinylated secondary antibodies (Vector Labs), goat anti-rabbit (polyclonal antibodies). Orange dotted circles highlight some cells considered positives for the particular receptor. Original magnification was x200. Figure 1E represents the average and SEM of number of PAR-positive cells as percent of the total cells per field.
###end p 19
###begin p 20
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-B</bold>
###xml 306 307 306 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
A-B. Polymerase Chain Reaction for detection of PARs message in J82 human urothelial carcinoma cell line. Figure 2A is a photomicrograph of the gel and Figure 2B represents the area under the curve as quantified using Image J software [74]. Primers used in this experiment are described in additional file 1 (Table 1).
###end p 20
###begin title 21
PAR-APs induce bladder inflammation
###end title 21
###begin p 22
###xml 97 98 97 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 338 340 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 401 403 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 424 426 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 474 476 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 637 639 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 770 772 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 875 877 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Next, we determined whether activation of PARs in mice would induce bladder inflammation. Figure 3 shows a representative photomicrograph demonstrating that an inflammatory response was mounted twenty-four hours after bladder instillation with PAR4-AP (10 muM). Inflammation secondary to PAR4-AP was characterized by vasodilation (Figure 4A), sub-epithelial infiltration of inflammatory cells (Figure 4B), and edema (Figure 4C). A high magnification photomicrograph (Figure 4D) indicates that the majority of inflammatory cells responding to PAR4-AP were polymorphonuclear [PMNs] leukocytes characteristic of acute bladder inflammation [32]. In addition, the cellular infiltrate expanded from submucosal layers towards the detrusor smooth muscle (green arrows in figure 3A) and within the detrusor nerve elements, previously shown to contain PAR4 (figure 9 of the reference [27]), are surrounded by inflammatory cells. Similar results were obtained 48 hours after bladder instillation with PAR4-AP with the addition of macrophages to the lesion (data not shown).
###end p 22
###begin p 23
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PAR4-AP induces bladder inflammation</bold>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
PAR4-AP induces bladder inflammation. Anesthetized female C57BL6 mice were catheterized, the bladder was emptied, and a volume of 200 mul of a solution of PAR4-AP (10 muM) was instilled into the urinary bladder. Twenty four hours later, bladders were removed, processed for histology, and stained with H&E. At low magnification, photomicrograph illustrates the distribution of inflammatory cells extending from the submucosa to deep regions in the detrusor smooth muscle (green arrows). Magnifications = x100
###end p 23
###begin p 24
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D. PAR4-AP induces bladder inflammation</bold>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 645 650 <span type="species:ncbi:10090">mouse</span>
A-D. PAR4-AP induces bladder inflammation. Anesthetized female C57BL6 mice were catheterized, the bladder was emptied, and a volume of 200 mul of a solution of PAR4-AP (10 muM) was instilled into the urinary bladder. Twenty four hours later, bladders were removed, processed for histology, and stained with H&E. A characteristic photomicrograph represents sub-urothelium inflammatory infiltrate around a blood vessel (A) and dilation of blood vessels (white arrow). At higher magnification (B), it was possible to visualize that the majority of inflammatory cells in response to PAR4-AP presented a characteristic "doughnut" shape indicative of mouse PMNs (green arrowhead). The submucosal edema is illustrated in C. Figure 4D illustrates inflammatory cells surrounding a structure resembling a nerve element (black arrow). Magnifications A = x200, B = x400, C = x200, and D = x400.
###end p 24
###begin p 25
###xml 194 195 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 294 296 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 313 315 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 332 334 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 357 359 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 429 430 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
Next, we compared the effect of 10 muM concentrations of PAR1-AP, PAR2-AP, and PAR-4-AP on the degree of PMN infiltration into the urinary bladder. The representative photomicrographs on figure 4 indicate that contrast to the control peptide which failed to induce bladder inflammation (Figure 5A), PAR1- (Figure 5B), PAR2- (Figure 5C), and PAR4-AP (Figure 5D) induced different densities of inflammatory cell infiltrate. Figure 6 summarizes the results obtained with different concentrations of PAR-APs. An inflammatory cell infiltrate was detected at concentrations as low as 0.1 muM and reached a peak at 10 muM PAR4-AP. These results indicate that, at least in the mouse bladder, the instillation of 10 muM PAR4-AP or 100 muM PAR1-AP induces a strong inflammatory reaction characterized by the highest number of PMNs infiltrating the bladder. Both PAR1-AP and PAR2-AP at 10 muM concentration induced bladder inflammation but the number of PMNs that infiltrated the urinary bladder was smaller than that observed with PAR4- AP (10 muM). No inflammation was observed in mice instilled with pyrogen-free saline or 10 muM control peptide dissolved in PBS.
###end p 25
###begin p 26
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-D. Comparison of different PAR-APs in inducing mouse bladder inflammation</bold>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
A-D. Comparison of different PAR-APs in inducing mouse bladder inflammation. Characteristic photomicrographs of bladders removed from female C57BL6 mice that received instillation of (A = control peptide; B = PAR1-AP; C = PAR2-AP, and D = PAR4-AP). All peptides were at the concentration of 10 muM and bladders were removed 24 hours after challenge. Of note, absence of inflammation following instillation with control peptide (A), submucosal PMN infiltrate induced by PAR1-AP (B), modest perivascular infiltration in response to PAR2-AP (C), and overwhelming PMN infiltration in response to PAR4-AP (D). Magnifications: A, B, C, and D = x200.
###end p 26
###begin p 27
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Effect of different concentrations of PAR1-, PAR2-, and PAR4-AP on PMNs migration</bold>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 378 383 <span type="species:ncbi:10090">mouse</span>
Effect of different concentrations of PAR1-, PAR2-, and PAR4-AP on PMNs migration. Anesthetized female C57BL6 mice were catheterized, the bladder was emptied, and a volume of 200 mul of a solution of control peptide (10 muM) or PAR1-, PAR2-, and PAR4-AP at different concentrations (0.1 to 1000 muM) was instilled into the urinary bladder. The number of PMNs migration into the mouse bladders was examined 24 hours after instillation (n = 8 for PAR4-AP and control peptide and n = 4 for PAR1-AP and PAR2-AP).
###end p 27
###begin p 28
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 552 556 552 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 734 736 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 986 988 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 993 995 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1032 1036 1026 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1123 1125 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 1178 1182 1172 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1212 1214 1206 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1250 1254 1244 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1262 1266 1256 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1350 1352 1344 1346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 556 560 <span type="species:ncbi:10090">mice</span>
###xml 761 777 <span type="species:ncbi:562">Escherichia coli</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 1036 1040 <span type="species:ncbi:10090">mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
PAR1-/- and PAR2-/- mice were used to determine whether those receptors were downstream of a common inflammatory cascade. We chose the following classical inflammatory stimuli: substance P, LPS, and antigen-challenge (in sensitized mice) because they were shown to depend on mast cells for eliciting bladder inflammation [7,8,27], and products of mast cell degranulation such as chymase and tryptase activate PAR1 [33,34] and PAR2 receptors [35,36], respectively. For this purpose, groups of anesthetized female, wild type (C57BL/6J), PAR1-/-, and PAR2-/- mice (n = 6-8) were instilled with saline, or with control inactive peptide (10 muM), or one of the following substances at concentrations known to induce inflammatory response [32]: substance P (10 muM), Escherichia coli LPS strain 055:B5 (100 mug/ml), DNP4-OVA (in sensitized mice; 1 mug/ml), PAR1-AP (10 muM), and PAR2-AP (10 muM). Twenty-four hours later, bladders were removed for quantification of PMN infiltration. Figures 7A and 7B summarize the results obtained. PAR1-/- mice presented a reduced response to substance P, LPS, and antigen stimulation (Figure 7A). However, the responses to PAR2-AP obtained in PAR1-/- mice were not altered (Figure 7B). The major difference between PAR1-/- and PAR2-/- mice is that the latter still presented an inflammatory response to antigen (Figure 7A).
###end p 28
###begin p 29
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A-B. </bold>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 224 234 224 234 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Figure 7A </bold>
###xml 408 418 405 415 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Figure 7B </bold>
###xml 727 731 721 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 738 742 732 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 282 298 <span type="species:ncbi:562">Escherichia coli</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
A-B. Comparison of the inflammatory responses (PMNs infiltration) obtained with wild type (C57BL/6J), PAR1-/-, and PAR2-/- mice. Responses were obtained 24 hours after bladder instillation with one of the listed substances. Figure 7A represents the response to substance P (10muM), Escherichia coli LPS strain 055:B5 (100 mug/ml), and DNP4-OVA (in sensitized mice; 1 mug/ml) compared to saline (black bars). Figure 7B represents the responses to PAR1-AP (10 muM) and PAR2-AP (10 muM) compared to control inactive peptide (10 muM). Number of mice = 6-8 per group. NS= not significant. Asterisks represent a statistically significant difference (p < 0.05) between the responses obtained with each pro-inflammatory stimuli in PAR1-/- or PAR2-/- and the respective response obtained in wild type mice.
###end p 29
###begin p 30
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 206 210 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 252 254 246 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 293 297 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 301 304 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p= </italic>
###xml 334 338 328 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 614 618 608 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 618 622 <span type="species:ncbi:10090">mice</span>
Regarding other inflammatory cells, bladders isolated from PAR1-/- and PAR2-/- presented equivalent number of mast cells when compared to wild type mice (mast cell/cross section: PAR1-/- = 9.7 +/- 1.1; PAR2-/- = 11.7 +/- 1.9; wild type = 8.3 +/- 0.6 ; p values = 0.30 when comparing WT to PAR1-/- and p= 0.10 when comparing WT to PAR2-/- animals). After stimulation with the pro-inflammatory stimuli, the bladder of wild type mice presented signs of mast cell activation by the presence of degranulation. In contrast, except for some perivascular infiltrate, few inflammatory cells were seen in the bladder of PAR1-/- mice in response to pro-inflammatory stimuli (data not shown). In addition, when mast cells were visible, there was no apparent sign of degranulation, which may reflect poor activation of those cells (data not shown).
###end p 30
###begin p 31
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 424 427 424 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 447 451 447 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 263 268 <span type="species:ncbi:10090">mouse</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
These results indicate that PAR1 receptors are essential for bladder inflammation secondary to several pro-inflammatory stimuli, while PAR-2 receptors seem to have a decreased role, at least in mediating the responses to antigen challenge. Because the transgenic mouse models used have been reported to be complete knockouts [18,37-42] and PAR2-AP has no effect on PAR2 knockout mice [43,44], we did not test PAR1-AP in PAR1-/-and PAR2-AP in PAR2 -/- mice.
###end p 31
###begin title 32
Discussion
###end title 32
###begin title 33
Role of PAR in bladder inflammation
###end title 33
###begin p 34
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Proteases that are released during inflammation and injury cleave PARs on the urothelium, detrusor muscle, and nerve elements to cause neurogenic bladder inflammation [45,46] and hyperalgesia [21,23]. As we demonstrated earlier by IHC, PARs are over-expressed in the bladder following cystitis induced by classical mediators such as LPS and SP [27].
###end p 34
###begin p 35
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 905 907 905 907 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 987 989 987 989 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 270 275 <span type="species:ncbi:9606">Human</span>
###xml 1025 1030 <span type="species:ncbi:9606">human</span>
###xml 1199 1204 <span type="species:ncbi:9606">human</span>
This study determined whether all four PAR receptors are expressed in human urothelial cell line. The presence of multiple PARs on the same cell is thought to extend the range of proteases a cell responds to rather than expand the range of intracellular responses [30]. Human transitional-cell carcinoma (J82) cells express various G protein-coupled receptors, and the presence of PARs in this cell line was based on the effects of thrombin, which induces a strong migration of J82 cells by a mechanism that involves Ca2+ mobilization and activation of Rho kinase leading to a reorganization of the cytoskeleton [29]. In addition to the J82 cell line, expression of PARs in RT4 bladder papilloma cells was inferred based on findings that RT4 cells respond to activators of PARs such as thrombin, tryptase, and PAR-activating peptides[30]. Those PAR activators induced a calcium independent phospholipase A2 with the consequent release of arachidonic acid and synthesis of prostaglandin E2 [30]. Since the presence of PARs in human urothelium was only based on circumstantial evidence, we determined whether J82 carcinoma cell line expresses PAR protein and RNA. Our results demonstrate that the J82 human urothelial cell line expresses all four PA receptors.
###end p 35
###begin p 36
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 872 874 872 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 998 1000 998 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1671 1673 1671 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1822 1824 1822 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 294 299 <span type="species:ncbi:10090">mouse</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
###xml 707 712 <span type="species:ncbi:10090">mouse</span>
###xml 754 759 <span type="species:ncbi:9606">human</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
###xml 880 885 <span type="species:ncbi:10090">Mouse</span>
###xml 1108 1113 <span type="species:ncbi:10090">mouse</span>
###xml 1246 1251 <span type="species:ncbi:10090">mouse</span>
###xml 1287 1292 <span type="species:ncbi:10090">mouse</span>
An additional goal of this paper was to determine whether PA receptors are part of the inflammatory cascade mediating the response of the urinary bladder to known pro-inflammatory stimuli. The stimuli were chosen because we have published evidence that each one of them when instilled into the mouse bladder produces inflammation: substance P [47], LPS [48], and antigen challenge of sensitized mice [10,11]. However, the present manuscript did not determine which endogenous substance is responsible for activation of PAR receptors, and therefore, the following discussion is based on the literature and not in the results of this manuscript. The information regarding endogenous activators of PARs in the mouse bladder is, unfortunately, scanty. While human connective tissue mast cells contain the enzymes chymase and tryptase, mice contain numerous related proteases [49-51]. Mouse mast cell protease-7 is a tryptase predominantly expressed in differentiated connective tissue-type mast cells [52]. Mast cell proteases mcpt5 (chymase), mcpt6 and 7 (tryptases) are expressed during the development of the mouse embryo [49]. However, to the best of our knowledge, there is no information regarding which particular tryptase is expressed in the mouse bladder and/or upregulated in this mouse model during inflammation. Although thrombin is a recognized physiological activator of PAR1 and PAR4, the endogenous enzymes responsible for activating PAR2 in urinary bladder are not known. Recently, it was demonstrated that the tissue kallikrein family of proteinases are able to regulate PAR signaling and may represent important endogenous regulators PAR1, PAR2, and PAR4 [53]. The latter are likely to be confirmed in the urinary tract, since members of the kallikrein family play a fundamental role in bladder physiology [54].
###end p 36
###begin p 37
###xml 490 492 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 604 606 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 683 685 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 766 770 764 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
Administration of PAR peptide agonists into the urinary bladder of mice elicited an inflammatory reaction characterized by edema and granulocyte infiltration. Interestingly, the inflammatory responses to PAR4-AP peaked at 10 muM and higher concentrations of this peptide (100 muM) failed to produce an additional increase in PMNs migration, but rather induced a lesser degree of inflammation. Several possibilities could explain this finding, including PAR desensitization and endocytosis [55], shedding of these receptors from the cells, as is the case of PAR1 in endothelial cells exposed to thrombin [56], and shedding of urothelial cells bearing these receptor, as we suggested [27]. Although we observed a potent inflammatory response secondary to PAR4-AP, PAR4-/- mice were not available in our laboratory at the time this project started. Nevertheless, our results emphasize the importance of this receptor in cystitis.
###end p 37
###begin p 38
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 77 81 77 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
In the present work, we determined that PAR1-/- and, to a lesser extent, PAR2-/- mice present decreased inflammatory responses to pro-inflammatory stimuli. The results obtained with PAR-deficient mice provide evidence indicating that substances known to stimulate mast cells, such as SP and antigen, induce a bladder inflammatory reaction that depends on PAR activation. In addition, these results indicate that toxins such as LPS, known to be released during bladder infection, also share the same PAR pathway.
###end p 38
###begin p 39
###xml 55 63 55 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 102 111 102 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 560 562 560 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 672 681 672 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 819 821 819 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 865 867 865 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 928 936 928 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 257 260 <span type="species:ncbi:10116">rat</span>
###xml 657 661 <span type="species:ncbi:10116">rats</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
###xml 824 829 <span type="species:ncbi:9606">human</span>
The authors acknowledge the lack of functional data on in vivo urinary bladder function at this time. In vitro experiments indicate that both trypsin and PAR-2 activating peptide (SLIGRL-NH(2)) produced a concentration-dependent contractile response in the rat urinary bladder preparations. These contractions were abolished by removal of the urinary bladder mucosa and were significantly reduced by the non-steroidal anti-inflammatory drug indomethacin [57]. The release of prostaglandins by PAR-2 activators seems to be partly mediated by the phospholipase A2 (iPLA2) [58]. These responses were enhanced in bladders isolated from cyclophosphamide-treated rats [45]. The in vitro work confirms the evidence that PAR activation leads to iPLA2-mediated prostaglandin release in human urothelial carcinoma cell line RT4 [30], human bladder microvascular endothelial [59,60], and normal urothelial cells [61]. However, there is no in vivo functional data on the effect of PAR stimulation on bladder urodynamic behavior.
###end p 39
###begin p 40
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 119 123 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 132 136 132 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 190 192 190 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 417 421 417 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 832 834 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 843 845 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1002 1004 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1005 1007 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 1022 1024 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 1060 1064 1057 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1134 1138 1131 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1189 1191 1186 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1226 1228 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 1064 1068 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
It is not clear why the experimental cystitis in PAR2-/- mice was not totally abolished, as seen in PAR1-/-. Both PAR1 -/- and PAR2 -/- mice have been well characterized [18,37-42]; see [62,63] for reviews. In addition, PAR2-AP has no effect on PAR2 knockout mice [43,44]. Nevertheless, compensatory mechanisms from other PA receptors could be possible. Regarding the difference of response between PAR1 -/- and PAR2 -/- mice, this may reflect a different role of the endogenous ligand since PAR1 is activated by thrombin, while PAR2 is activated by mast cell tryptase [23]. It has to be taken into consideration that some of the PAR agonists, such as thrombin, activate more than one receptor. Indeed, in addition to PAR1, thrombin activates PAR4 [20] and type-II TGFbeta receptors and consequently leads to their down regulation [64]. PAR1 [65] and possibly PAR3 and PAR4 are involved in vascular inflammation, but the primary role for PAR2 seems to be cytoprotection in the gastro intestinal tract [66,67] and airways [68]. It was reported that whereas PAR1-/- mice do not mount inflammatory responses to a variety of stimuli, PAR2-/- mice present a delayed microvascular inflammation [40] and a reduced encephalomyelitis [69].
###end p 40
###begin p 41
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1150 1154 1150 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1165 1169 1165 1169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 755 761 <span type="species:ncbi:9606">humans</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
Another possible explanation for the discrepancy between PAR1 and PAR2 is the differential localization of the two PARs in urinary bladder. PAR2 is much more abundant than PAR1 in the urothelium. However, following acute and chronic inflammation, probably because of the shedding of urothelial cells bearing PARs, both PAR1 and PAR2 expression are reduced [24]. Alternatively, the association between PAR1 and PAR2 with vallinoid receptors [70] in sensory C fibers deserves further investigation as a possible explanation for a differential participation of PAR1 and PAR2 in inflammation. Another hypothesis points to the control of PAR by a metalloproteinase-dependent shedding of proteins from the cell surface [56]. More recently, it has been shown in humans that the downstream signal transduction cascade in response to PAR2 but not PAR1 depends on an interacting partner, the Jun activation domain-binding protein 1 (Jab1) [71]. Taken together, data from literature suggests a differential fate for PAR1 receptor as compared to PAR2 receptor, which could help to explain the difference in response to inflammatory stimuli in the bladder of PAR1-/- versus PAR2-/- mice. Regardless of the receptor type, our findings demonstrate an overwhelming participation of PARs in bladder inflammation and place them in a central role controlling the communication between the immune system represented by mast cells, the sensory system represented by SP, and infection represented by LPS.
###end p 41
###begin title 42
Conclusion
###end title 42
###begin p 43
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
This work indicates an overriding participation of PAR1 receptors in bladder inflammation, provides a working model for the involvement of a network of transcripts downstream of PAR1 activation, and evokes testable hypotheses regarding the regulation of PAR. It remains to be determined whether PAR1 receptor blockade or selective gene silencing of transcripts downstream of PAR activation will ameliorate the clinical manifestation of cystitis. Inhibiting of PAR up-regulation using small interfering RNA technology, as confirmed by immunoblotting, should substantially reduced bladder inflammatory response as it has been shown in other systems [36].
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Urothelial Cell Culture
###end title 45
###begin p 46
###xml 445 447 438 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 226 232 <span type="species:ncbi:9913">bovine</span>
Human bladder carcinoma cell line J82 (HTB-1) were obtained from the American Tissue Culture Collection. J82 cells were seeded onto a 4-chambers slide and cultured in Minimum Essential Media (MEM), supplemented with 10% fetal bovine serum (FBS), 100 muM non-essential amino acids, 1 mM sodium pyruvate, 100 U/ml penicillin/streptomycin and 2 x MEM Vitamin Solution. Cells were maintained at 37degreesC in a humidified atmosphere containing 5% CO2 until 90% confluence was reached. The medium was removed and cells were fixed in 10% formalin.
###end p 46
###begin title 47
###xml 12 17 <span type="species:ncbi:9606">human</span>
PARs IHC in human cell line
###end title 47
###begin p 48
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 850 851 850 851 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1225 1229 1225 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 552 556 <span type="species:ncbi:9925">goat</span>
###xml 562 568 <span type="species:ncbi:9986">rabbit</span>
###xml 634 645 <span type="species:ncbi:3704">horseradish</span>
Fixed cells were processed for routine immunohistochemistry according to published methods [27]. All reagent incubations (30 min) and washes were performed at room temperature. Normal blocking serum (Vector Labs, Burlingham, CA) was placed on all slides for 10 min and, after a brief rinse in PBS, sections were incubated with primary polyclonal (Santa Cruz Biotechnology, Santa Cruz, CA) antibodies: PAR-1 (1:20), PAR-2 (1:100), PAR-3 (1:5), and PAR-4 (1:50). Slides were washed and incubated with biotinylated secondary antibodies (Vector Labs), and goat anti-rabbit (polyclonal antibodies). After rinsing in PBS, the avidin-biotin-horseradish peroxidase complex reagent (ABC-HRP, Vector Labs) was added. Slides were washed and treated with the chromogen 3,3'-diaminobenzidine (DAB, Biomeda, Foster City, CA) (two changes, 5 min each), rinsed in dH20, counterstained with hematoxylin, dehydrated, and coverslipped with Permount (Fisher Scientific) mounting media. Positive cells were visualized by microscope (Eclipse E600, Nikon, Lewisville, TX). All tissues were photographed at room temperature by a digital camera (DXM1200; Nikon). Five random fields per slide were counted. Images were analyzed with Image-Pro Analyzer(R) (Media Cybernetics Inc.; Silver Spring, MD). The number of positive cells per field at 200 x magnification was calculated as percent of the total cells (200 x magnification). Results are presented as average and standard error of the mean.
###end p 48
###begin title 49
###xml 46 51 <span type="species:ncbi:9606">human</span>
PARs Polymerase chain reaction assay (PCR) in human cell line
###end title 49
###begin p 50
###xml 671 673 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 737 738 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 791 793 789 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
Total RNA was extracted in Ultraspec RNA solution (Biotecx Laboratories Inc. Houston, TX) according to the manufacturer's instructions. The amount and quality of the RNA were verified by measuring the absorbance at 260 and 280 nm, and by electrophoresing the samples on a formaldehyde/agarose gel. Oligo(dT)-primed reverse transcription of RNA was performed with the SuperScript First-Strand Synthesis System for reverse transcriptase-polymerase chain reaction (RT-PCR) (Invitrogen, Carlsbad, CA), using 5 mug of RNA for each reaction. Following reverse transcription, PCR amplifications were performed from 2 mul of each cDNA. Primer pairs were designed using Primer 3 [72]. Details of the primer sequences are given in additional file 1 (Table 1) and were designed according to reference [73]. The designed primers shared 100% homology with the target sequence but no significant homology with other sequences.
###end p 50
###begin p 51
###xml 443 447 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 792 794 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
The PCR program consisted of one preincubation at 94degreesC for 2 min and 40 cycles at 94degreesC for 30 s, 55degreesC for 30 s (50degreesC for 1 min for PAR1), 68degreesC for 1 min (3 min for PAR1), and 68degreesC for 5 min. All PCR reactions were performed with a Robocycler Gradient 96 with a heated lid (Stratagene, La Jolla, CA) in 50 mul of 1 x PCR buffer, 1.5 mM MgCl2, forward and reverse primers at 0.2 muM, 200 muM dNTP, and 1 U of Taq DNA polymerase (Invitrogen). Twenty microliters of the amplification mixtures were analyzed by agarose gel electrophoresis. Beta-actin was used as positive control. Images of the PCR products were taken using the FluorChem HD digital darkroom (Alpha Innotech, San Leandro, CA) and the area under the curve was quantified using Image J software [74].
###end p 51
###begin title 52
Animals
###end title 52
###begin p 53
###xml 206 209 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 134 139 <span type="species:ncbi:9606">Human</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
All animal experimentation described here was performed in conformity with the "Guiding Principles for Research Involving Animals and Human Beings (OUHSC Animal Care & Use Committee protocol #05-088I). PAR1-/-[38], PAR2-/- [75], and C57BL/6J mice were used in this research. C57BL/6J mice were used as wild type since PAR1-/- and PAR2-/- were enriched in this background.
###end p 53
###begin title 54
Antigen sensitization protocol
###end title 54
###begin p 55
###xml 231 233 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 49 54 <span type="species:ncbi:9606">human</span>
One group of mice was sensitized with 1 mug DNP4-human serum albumin (HSA) in 1 mg alum on days 0, 7, 14, and 21, intraperitoneally (i.p.). This protocol induces sustained levels of IgE antibodies up to 56 days post-sensitization [76]. One week after the last sensitization, cystitis was induced as described below.
###end p 55
###begin title 56
Induction of cystitis
###end title 56
###begin p 57
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 672 674 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 725 727 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 748 750 744 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 775 777 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 518 534 <span type="species:ncbi:562">Escherichia coli</span>
###xml 612 616 <span type="species:ncbi:10090">mice</span>
###xml 1124 1128 <span type="species:ncbi:10090">mice</span>
###xml 1198 1202 <span type="species:ncbi:10090">mice</span>
Acute cystitis was induced in 8 mice per group, as described previously [27,32,48,77,78]. Briefly, female wild type (C57BL/6J), PAR1-/-, and PAR2-/- mice were anesthetized (ketamine 200 mg/kg and xylazine 2.5 mg/kg, i.p.), then transurethrally catheterized (24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah), and the urine was drained by applying slight digital pressure to the lower abdomen. The urinary bladders were instilled with 200 mul of one of the following substances: pyrogen-free saline, SP (10 muM), Escherichia coli LPS strain 055:B5 (Sigma, St. Louis, MO; 100 mug/ml), antigen (in sensitized mice; DNP4-OVA 1 mug/ml), control inactive peptide (LRGILS [55]), or PAR- activating peptides (PAR1-AP = SFFLRN [55]; PAR2-AP = SLIGRL [55]; and PAR4-AP = AYPGKF [79]). Substances were infused at a slow rate to avoid trauma and vesicoureteral reflux (18). To ensure consistent contact of substances with the bladder, infusion was repeated twice within a 30-min interval and a 1-ml TB syringe was kept on the catheter end to retain the intravesical solution for at least for 1 hour. The catheter was removed, and mice were allowed to void normally. Twenty-four hours after instillation, mice were euthanized with pentobarbital (200 mg/kg, i.p.), and the bladders were removed rapidly.
###end p 57
###begin title 58
Quantification of inflammation
###end title 58
###begin p 59
###xml 304 308 304 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 611 612 608 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
H&E stained sections were visualized under microscope (Eclipse E600, Nikon, Lewisville, TX). All tissues were photographed at room temperature by a digital camera (DXM1200; Nikon). Exposure times were held constant when acquiring images from different groups. Images were analyzed with Image-Pro Analyzer(R) (Media Cybernetics Inc.; Silver Spring, MD 20910). The number of polymorphonuclear [PMNs] leukocytes was counted in a blinded fashion in 10 random fields per slide in two non-consecutive sections per urinary bladder at 200 x magnification. The number of PMNs was normalized per cross-sectional area (mum2). The number of infiltrate PNMs was the most reproducible sign of acute bladder inflammation and, therefore, it was used for quantification.
###end p 59
###begin title 60
Statistical Analysis
###end title 60
###begin p 61
Data in figures represent the mean +/- SEM of the indicated number of samples. The difference between two mean values was analyzed with the unpaired Student's t-test. Since we did not assume equal variance because the variance of PMN population is unknown, p values were correct using a Welch's test (GraphPad Prism software version 4.0; GraphPad Software, Inc. San Diego, CA 92130). A value of p < 0.05 was considered statistically significant.
###end p 61
###begin title 62
Materials
###end title 62
###begin p 63
PAR1-AP, PAR2-AP, and PAR4-AP were synthesized at the Molecular Biology Resource Facility, William K. Warren Medical Research Institute, OUHSC, as carboxyl-terminal amides, purified by high-pressure liquid chromatography, and characterized by mass spectroscopy. Peptide solutions were made fresh in PBS from powder.
###end p 63
###begin title 64
Competing interests
###end title 64
###begin p 65
The author(s) declare that they have no competing interests.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
###xml 52 55 52 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RS </bold>
###xml 106 110 106 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MRD </bold>
###xml 177 181 177 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PAG </bold>
###xml 239 243 239 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 252 256 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 262 266 262 266 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CKD </bold>
###xml 316 319 316 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ID </bold>
###xml 360 363 360 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MI </bold>
###xml 426 430 426 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink">REH </bold>
###xml 493 496 493 496 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CS </bold>
###xml 503 507 503 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MRS </bold>
###xml 532 536 532 536 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CAD </bold>
###xml 606 610 606 610 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MRS </bold>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 568 573 <span type="species:ncbi:9606">human</span>
All authors read and approved the final manuscript. RS conceived of the study and drafted the manuscript, MRD participated in the design and reviewed the morphological results, PAG participated in the experimental design and provided PAR1 -/- and PAR2 -/- mice, CKD participated in design and proper use of PAR-APS, ID participated in the experimental design, MI participated in its design and helped to draft the manuscript, REH participated in its design and helped to draft the manuscript, CS helped MRS with animal experiments, CAD performed the experiments using human urothelial cell line (J82), and MRS participated in its design, carried out the animal experiments, and removed the tissues.
###end p 67
###begin title 68
Supplementary Material
###end title 68
###begin title 69
Additional file 1
###end title 69
###begin p 70
Primers for PCR. Table 1
###end p 70
###begin p 71
Click here for file
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
Supported by National Institutes of Health grants DK 55828-01 and DK066101-01 (R.S.).
###end p 73
###begin article-title 74
###xml 156 164 <span type="species:ncbi:9606">patients</span>
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder
###end article-title 74
###begin article-title 75
Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma
###end article-title 75
###begin article-title 76
The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence
###end article-title 76
###begin article-title 77
Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis
###end article-title 77
###begin article-title 78
Critical role of mast cells in inflammatory diseases and the effect of acute stress
###end article-title 78
###begin article-title 79
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Elevated mast cell tryptase in the urine of patients with interstitial cystitis
###end article-title 79
###begin article-title 80
Subtypes of bladder mast cells in interstitial cystitis
###end article-title 80
###begin article-title 81
Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study
###end article-title 81
###begin article-title 82
Lack of neurokinin-1 receptor expression affects tissue mast cell numbers but not their spatial relationship with nerves
###end article-title 82
###begin article-title 83
Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism
###end article-title 83
###begin article-title 84
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice
###end article-title 84
###begin article-title 85
Sensitization of Pelvic Nerve Afferents and Mast Cell Infiltration in the Urinary Bladder Following Chronic Colonic Irritation is Mediated by Neuropeptides
###end article-title 85
###begin article-title 86
###xml 138 143 <span type="species:ncbi:10090">mouse</span>
Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants
###end article-title 86
###begin article-title 87
###xml 35 40 <span type="species:ncbi:9606">human</span>
Cysteinyl leukotriene D4 increases human detrusor muscle responsiveness to histamine
###end article-title 87
###begin article-title 88
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients
###end article-title 88
###begin article-title 89
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
###end article-title 89
###begin article-title 90
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability
###end article-title 90
###begin article-title 91
Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway
###end article-title 91
###begin article-title 92
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
###end article-title 92
###begin article-title 93
Protease-activated receptors: contribution to physiology and disease
###end article-title 93
###begin article-title 94
Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia
###end article-title 94
###begin article-title 95
###xml 83 93 <span type="species:ncbi:10141">guinea pig</span>
Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea pig submucosal neurons
###end article-title 95
###begin article-title 96
Protease-activated receptors in inflammation, neuronal signaling and pain
###end article-title 96
###begin article-title 97
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
###end article-title 97
###begin article-title 98
International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors
###end article-title 98
###begin article-title 99
Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology
###end article-title 99
###begin article-title 100
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder
###end article-title 100
###begin article-title 101
Tumor cells augment the factor Xa-catalyzed conversion of prothrombin to thrombin
###end article-title 101
###begin article-title 102
###xml 80 85 <span type="species:ncbi:9606">human</span>
Identification of G protein-coupled receptors potently stimulating migration of human transitional-cell carcinoma cells
###end article-title 102
###begin article-title 103
Stimulation of protease activated receptors on RT4 cells mediates arachidonic acid release via Ca2+ independent phospholipase A2
###end article-title 103
###begin article-title 104
Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers
###end article-title 104
###begin article-title 105
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation
###end article-title 105
###begin article-title 106
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 43 48 <span type="species:ncbi:9606">human</span>
Human chymase stimulates Ca2+ signaling in human polymorphonuclear cells
###end article-title 106
###begin article-title 107
Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts
###end article-title 107
###begin article-title 108
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice
###end article-title 108
###begin article-title 109
Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation
###end article-title 109
###begin article-title 110
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
###end article-title 110
###begin article-title 111
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Biological consequences of thrombin receptor deficiency in mice
###end article-title 111
###begin article-title 112
The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia
###end article-title 112
###begin article-title 113
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Delayed onset of inflammation in protease-activated receptor-2-deficient mice
###end article-title 113
###begin article-title 114
Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells
###end article-title 114
###begin article-title 115
###xml 81 86 <span type="species:ncbi:10090">mouse</span>
Effect of protease-activated receptor-2 deficiency on allergic dermatitis in the mouse ear
###end article-title 115
###begin article-title 116
Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms
###end article-title 116
###begin article-title 117
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Colonic hyperalgesia triggered by proteinase-activated receptor-2 in mice: involvement of endogenous bradykinin
###end article-title 117
###begin article-title 118
###xml 110 114 <span type="species:ncbi:10116">rats</span>
Protease-activated receptor-2-mediated contraction of urinary bladder is enhanced in cyclophosphamide-treated rats
###end article-title 118
###begin article-title 119
Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism
###end article-title 119
###begin article-title 120
Neurokinin-1 (NK-1) receptor is required in antigen-induced cystitis
###end article-title 120
###begin article-title 121
LPS-sensory peptide communication in experimental cystitis
###end article-title 121
###begin article-title 122
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
The expression pattern of three mast cell specific proteases during mouse development
###end article-title 122
###begin article-title 123
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Requirement of c-jun transcription factor on the mouse mast cell protease-6 expression in the mast cells
###end article-title 123
###begin article-title 124
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse chromosome 17A3.3 contains thirteen genes that encode functional tryptic-like serine proteases with distinct tissue and cell expression patterns
###end article-title 124
###begin article-title 125
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
Transcriptional regulation of mouse mast cell protease-7 by TGF-beta
###end article-title 125
###begin article-title 126
Proteinase-activated receptors, targets for kallikrein signaling
###end article-title 126
###begin article-title 127
Integrative control of the lower urinary tract: preclinical perspective
###end article-title 127
###begin article-title 128
Proteinase-activated receptors
###end article-title 128
###begin article-title 129
Regulated shedding of PAR1 N-terminal exodomain from endothelial cells
###end article-title 129
###begin article-title 130
###xml 58 61 <span type="species:ncbi:10116">rat</span>
Protease-activated receptor-2-mediated contraction in the rat urinary bladder: the role of urinary bladder mucosa
###end article-title 130
###begin article-title 131
###xml 115 118 <span type="species:ncbi:10116">rat</span>
Possible involvement of Ca2+-independent phospholipase A2 in protease-activated receptor-2-mediated contraction of rat urinary bladder
###end article-title 131
###begin article-title 132
###xml 60 65 <span type="species:ncbi:9606">human</span>
Prostacyclin production in tryptase and thrombin stimulated human bladder endothelial cells: effect of pretreatment with phospholipase A2 and cyclooxygenase inhibitors
###end article-title 132
###begin article-title 133
Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells
###end article-title 133
###begin article-title 134
###xml 38 43 <span type="species:ncbi:9606">human</span>
Phospholipid metabolite production in human urothelial cells after protease-activated receptor cleavage
###end article-title 134
###begin article-title 135
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Extracellular mediators in atherosclerosis and thrombosis: lessons from thrombin receptor knockout mice
###end article-title 135
###begin article-title 136
Protease-activated receptors in hemostasis, thrombosis and vascular biology
###end article-title 136
###begin article-title 137
Thrombin induces endocytosis of endoglin and type-II TGF-beta receptor and down-regulation of TGF-beta signaling in endothelial cells
###end article-title 137
###begin article-title 138
###xml 126 131 <span type="species:ncbi:9606">human</span>
Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries
###end article-title 138
###begin article-title 139
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
###end article-title 139
###begin article-title 140
Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2
###end article-title 140
###begin article-title 141
A protective role for protease-activated receptors in the airways
###end article-title 141
###begin article-title 142
Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis
###end article-title 142
###begin article-title 143
###xml 77 88 <span type="species:ncbi:10141">guinea pigs</span>
Protease-activated receptor-2 activation exaggerates TRPV1-mediated cough in guinea pigs
###end article-title 143
###begin article-title 144
Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1
###end article-title 144
###begin article-title 145
###xml 125 130 <span type="species:ncbi:9606">human</span>
Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells
###end article-title 145
###begin article-title 146
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1
###end article-title 146
###begin article-title 147
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Anti-immunoglobulin E antibody treatment blocks histamine release and tissue contraction in sensitized mice
###end article-title 147
###begin article-title 148
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation
###end article-title 148
###begin article-title 149
Gene expression profiling of inflammatory bladder disorders
###end article-title 149
###begin article-title 150
Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function
###end article-title 150

